WASHINGTON (AP) – The federal government on Wednesday outlined a comprehensive plan to make COVID-19 vaccines freely available to all Americans, even as polls show a strong ground of skepticism across the ground. .
In a report with a “playbook” for Congress and states and localities, federal health agencies and the Department of Defense abandoned complex plans for the vaccination campaign to begin slowly in January or possibly later this year, after all Ramp wants a shot to reach his American. The Pentagon is involved with the distribution of vaccines, but civilian health workers will be the ones to deliver the shots.
The campaign “is much larger in scope and complexity than vaccine responses related to seasonal influenza or other previous outbreaks,” said the Playbook for States from the Centers for Disease Control and Prevention.
– For most vaccines, people will require two doses, 21 to 28 days apart. Double-dose vaccines have to come from the same drugmaker. There may be multiple vaccines from different manufacturers approved and available.
– Vaccination of the American population will not be a sprint but a marathon. Initially limited supplies of vaccines may be available, and attention will be given to the protection of health workers, other essential staff and people from vulnerable groups. The CDC’s Advisory Committee on Immunization Practices, the National Academy of Medicine, and other organizations are working on priorities for the first phase. In the second and third phase, vaccination will be spread across the country.
– The vaccine itself will be free of charge, and patients will not be taken out of pocket to administer the shots, thanks to billions of dollars in Congress-approved taxpayer funds and allocated by the Trump administration.
– States and local communities will need to formulate precise plans to obtain and deliver vaccines locally, some of which will require special handling such as refrigeration or freezing. States and cities have one month to submit schemes.
Some broad components of the federal plan have already been discussed, but Wednesday’s reports attempt to put key details into a broader framework. The delivery operation is taking place under the umbrella of taunting momentum, a White House-backed initiative once a vaccine is given, which is expected to be an emergency use approval by the Food and Drug Administration, with millions of ships ready. Several formulations are being tested last.
But the entire enterprise is facing public skepticism. Only half of Americans said they would be vaccinated in an Associated Press poll taken in May. Of those who would not get vaccinated, most said they were concerned about safety. To effectively protect the nation from coronaviruses, experts say 70% of Americans should either be vaccinated or have their own immunity from fighting COVID-19.
Polls have since raised questions about whether the government is trying to apply COVID-19 treatments and vaccines to help President Donald Trump’s reunion opportunities.
Prior to the Republican National Convention in August, the FDA approved authorization for the treatment of COVID-19 patients with the plasma of those recovered, although some government scientists were not sure the clinical evidence Were sufficiently strong. And last week it was reported that Michael Capto, the political appointee of the Department of Health and Human Services, tried to gain editorial control over a weekly scientific publication from the Centers for Disease Control and Prevention.
As public confidence in core health agencies has risen, Trump administration officials have been forced to play for defense.
HHS Secretary Alex Azar said in a statement on Wednesday, “We are working closely with our state and local public health partners. To ensure that Americans can get the vaccine as soon as possible and to be vaccinated with confidence Can. ” “Americans should know that the vaccine development process is being driven entirely by science and data.”
This can be a difficult sale. In the AP poll, 1 in 5 Americans said they would not receive the coronavirus virus vaccine, and 31% said they were unsure.